Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-220277
Filing Date
2014-06-02
Accepted
2014-05-30 18:40:09
Documents
3
Period of Report
2014-05-30

Document Format Files

Seq Description Document Type Size
1 6-K d734465d6k.htm 6-K 10938
2 EX-99.1 d734465dex991.htm EX-99.1 9249
3 GRAPHIC g734465ex99_1pg01.jpg GRAPHIC 10554
  Complete submission text file 0001193125-14-220277.txt   35839
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 14881768
SIC: 2834 Pharmaceutical Preparations